Cancer stem cells and individualized therapy

Saranya Chumsri, Pornima Phatak, Martin J. Edelman, Nazanin Khakpour, Anne W. Hamburger, Angelika M. Burger

Research output: Contribution to journalReview article

23 Citations (Scopus)

Abstract

The concept of individualized cancer chemotherapy emerged three decades ago from the observation that a small fraction of cells in primary tumors can form colonies in soft agar similar to stem cells of the hematopoietic system. In a series of retrospective and prospective clinical studies, clonogenic tumor growth and effects of anticancer agents on the putative cancer stem cells were assessed as predictive factors. The results of these trials showed that clonogenic growth is associated with poor outcome and drug resistance. Recent breakthroughs enabling isolation and the molecular classification of cancer stem cells have renewed interest in cancer stem cells as a therapeutic target. Here, we provide a current overview of cancer stem cell biology and highlight possibilities for targeted intervention with existing and novel experimental anticancer agents.

Original languageEnglish (US)
Pages (from-to)165-174
Number of pages10
JournalCancer Genomics and Proteomics
Volume4
Issue number3
StatePublished - May 2007
Externally publishedYes

Fingerprint

Neoplastic Stem Cells
Cell- and Tissue-Based Therapy
Stem cells
Antineoplastic Agents
Tumors
Hematopoietic System
Neoplasms
Cytology
Growth
Drug Resistance
Chemotherapy
Agar
Cell Biology
Stem Cells
Prospective Studies
Drug Therapy
Pharmaceutical Preparations
Therapeutics

Keywords

  • Cancer stem cells
  • Clonogenicity
  • Human tumor stem cell assay (HTCA)
  • Review
  • Side population

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Cancer Research
  • Biochemistry

Cite this

Chumsri, S., Phatak, P., Edelman, M. J., Khakpour, N., Hamburger, A. W., & Burger, A. M. (2007). Cancer stem cells and individualized therapy. Cancer Genomics and Proteomics, 4(3), 165-174.

Cancer stem cells and individualized therapy. / Chumsri, Saranya; Phatak, Pornima; Edelman, Martin J.; Khakpour, Nazanin; Hamburger, Anne W.; Burger, Angelika M.

In: Cancer Genomics and Proteomics, Vol. 4, No. 3, 05.2007, p. 165-174.

Research output: Contribution to journalReview article

Chumsri, S, Phatak, P, Edelman, MJ, Khakpour, N, Hamburger, AW & Burger, AM 2007, 'Cancer stem cells and individualized therapy', Cancer Genomics and Proteomics, vol. 4, no. 3, pp. 165-174.
Chumsri S, Phatak P, Edelman MJ, Khakpour N, Hamburger AW, Burger AM. Cancer stem cells and individualized therapy. Cancer Genomics and Proteomics. 2007 May;4(3):165-174.
Chumsri, Saranya ; Phatak, Pornima ; Edelman, Martin J. ; Khakpour, Nazanin ; Hamburger, Anne W. ; Burger, Angelika M. / Cancer stem cells and individualized therapy. In: Cancer Genomics and Proteomics. 2007 ; Vol. 4, No. 3. pp. 165-174.
@article{768d4177d4194f2c90587cda726cfa4f,
title = "Cancer stem cells and individualized therapy",
abstract = "The concept of individualized cancer chemotherapy emerged three decades ago from the observation that a small fraction of cells in primary tumors can form colonies in soft agar similar to stem cells of the hematopoietic system. In a series of retrospective and prospective clinical studies, clonogenic tumor growth and effects of anticancer agents on the putative cancer stem cells were assessed as predictive factors. The results of these trials showed that clonogenic growth is associated with poor outcome and drug resistance. Recent breakthroughs enabling isolation and the molecular classification of cancer stem cells have renewed interest in cancer stem cells as a therapeutic target. Here, we provide a current overview of cancer stem cell biology and highlight possibilities for targeted intervention with existing and novel experimental anticancer agents.",
keywords = "Cancer stem cells, Clonogenicity, Human tumor stem cell assay (HTCA), Review, Side population",
author = "Saranya Chumsri and Pornima Phatak and Edelman, {Martin J.} and Nazanin Khakpour and Hamburger, {Anne W.} and Burger, {Angelika M.}",
year = "2007",
month = "5",
language = "English (US)",
volume = "4",
pages = "165--174",
journal = "Cancer Genomics and Proteomics",
issn = "1109-6535",
publisher = "International Institute of Anticancer Research",
number = "3",

}

TY - JOUR

T1 - Cancer stem cells and individualized therapy

AU - Chumsri, Saranya

AU - Phatak, Pornima

AU - Edelman, Martin J.

AU - Khakpour, Nazanin

AU - Hamburger, Anne W.

AU - Burger, Angelika M.

PY - 2007/5

Y1 - 2007/5

N2 - The concept of individualized cancer chemotherapy emerged three decades ago from the observation that a small fraction of cells in primary tumors can form colonies in soft agar similar to stem cells of the hematopoietic system. In a series of retrospective and prospective clinical studies, clonogenic tumor growth and effects of anticancer agents on the putative cancer stem cells were assessed as predictive factors. The results of these trials showed that clonogenic growth is associated with poor outcome and drug resistance. Recent breakthroughs enabling isolation and the molecular classification of cancer stem cells have renewed interest in cancer stem cells as a therapeutic target. Here, we provide a current overview of cancer stem cell biology and highlight possibilities for targeted intervention with existing and novel experimental anticancer agents.

AB - The concept of individualized cancer chemotherapy emerged three decades ago from the observation that a small fraction of cells in primary tumors can form colonies in soft agar similar to stem cells of the hematopoietic system. In a series of retrospective and prospective clinical studies, clonogenic tumor growth and effects of anticancer agents on the putative cancer stem cells were assessed as predictive factors. The results of these trials showed that clonogenic growth is associated with poor outcome and drug resistance. Recent breakthroughs enabling isolation and the molecular classification of cancer stem cells have renewed interest in cancer stem cells as a therapeutic target. Here, we provide a current overview of cancer stem cell biology and highlight possibilities for targeted intervention with existing and novel experimental anticancer agents.

KW - Cancer stem cells

KW - Clonogenicity

KW - Human tumor stem cell assay (HTCA)

KW - Review

KW - Side population

UR - http://www.scopus.com/inward/record.url?scp=34249290073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249290073&partnerID=8YFLogxK

M3 - Review article

C2 - 17878520

AN - SCOPUS:34249290073

VL - 4

SP - 165

EP - 174

JO - Cancer Genomics and Proteomics

JF - Cancer Genomics and Proteomics

SN - 1109-6535

IS - 3

ER -